Showing results (501-510 of 3,868) with videos related to
Sort By:
Pageof 387
Cancer Biology & Therapy|November 16, 2006
Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancerCharles N Landen, William M Merritt, Lingegowda S Mangala, et al.Cancer Biology & Therapy|November 16, 2006
17beta-estradiol and tamoxifen stimulate rapid and transient ERK activationin MCF-7 cells via distinct signaling mechanismsHasina Visram, Peter A GreerCancer Biology & Therapy|November 18, 2006
TSA-induced cell death in prostate cancer cell lines is caspase-2 dependent and involves the PIDDosomeAgshin F Taghiyev, Natalya V Guseva, Rebecca A Glover, et al.Cancer Biology & Therapy|September 14, 2006
Randomized discontinuation trial of sorafenib (BAY 43-9006)Lokesh Jain, Jürgen Venitz, William D FiggCancer Biology & Therapy|May 7, 2005
Genetic response to DNA damage: proapoptotic targets of RhoB include modules for p53 response and susceptibility to Alzheimer's diseaseUma Kamasani, George C PrendergastCancer Biology & Therapy|May 27, 2005
Dendritic cells and melanoma tumorigenesis: an insightMahmoud R HusseinCancer Biology & Therapy|May 27, 2005
Comparative in vitro properties and clinical pharmacokinetics of Paclitaxel following the administration of taxol(r) and paxene(r)Charity D Scripture, Janos Szebeni, Walter J Loos, et al.Cancer Biology & Therapy|August 6, 2005
The histone deacetylase inhibitor, Trichostatin A, enhances radiation sensitivity and accumulation of gammaH2A.XTom C Karagiannis, K N Harikrishnan, Assam El-OstaCancer Biology & Therapy|August 6, 2005
In vivo and in vitro inhibition of pancreatic cancer growth by targeted alpha therapy using 213Bi-CHX.A"-C595Chang F Qu, Yan J Songl, Syed M A Rizvi, et al.Cancer Biology & Therapy|August 6, 2005
MAGED4-expression in renal cell carcinoma and identification of an HLA-A*25-restricted MHC class I ligand from solid tumor tissueBjörn F Krämer, Oliver Schoor, Tobias Krüger, et al.Pageof 387